A Transformational Gift for Children’s Health

Eric M. Mindich, a member of Mount Sinai’s Boards of Trustees, and his wife, Stacey Mindich, have provided a leadership gift to advance groundbreaking science to improve children’s health. In recognition of their generosity, Mount Sinai’s Child Health and Development Institute recently was renamed The Mindich Child Health and Development Institute (MCHDI).

“Eric and Stacey’s extraordinarily generous gift represents a critical step toward Mount Sinai’s goal of transforming children’s health,” says Kenneth L. Davis, MD, President and Chief Executive Officer of The Mount Sinai Medical Center.

(more…)

Mount Sinai Streamlines its Research Administration Enterprise

The Icahn School of Medicine at Mount Sinai has begun rolling out a series of projects for investigators in basic, translational, and clinical research that will streamline the research administration structure and make it easier to initiate and submit protocols and compete for funding.

“We are transforming and improving the research administration enterprise on behalf of our investigators,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn School of Medicine at Mount Sinai and Executive Vice President for Academic Affairs of The Mount Sinai Medical Center. “This vital endeavor underscores our commitment to supporting innovative and highly competitive research that will lead to groundbreaking treatments for human diseases.”

(more…)

New Discoveries in Head and Neck Cancers

Shutting down inflammation within the body, and then harnessing the immune system to recognize and destroy cancer cells, could provide the one-two punch needed to effectively treat head and neck cancers, according to researchers at Icahn School of Medicine at Mount Sinai.

Research into the pivotal role played by the inflammatory molecule inducible nitric oxide synthase (iNOS) in promoting cancer growth and immune evasion is being led by Andrew G. Sikora, MD, PhD, Assistant Professor and Director of Head and Neck Translational Research in the Department of Otolaryngology, Head and Neck Surgery.

(more…)

First Generation Scholars

In 2008, a first-year medical student named Jennifer Ling developed a program called the First Generation College Application Essay Writing and Scholarship Program, under the sponsorship of Students for Equal Opportunity in Medicine (SEOM). There were six students in the program, all of whom enrolled seeking help with their college application essays.

Three years later, Jennifer’s program merged with the Mount Sinai Scholars Program, a tutoring program originally sponsored by Mount Sinai’s Department of Health Education. The combined program was renamed the First Generation Scholars Program, and continues as an SEOM-sponsored program. Since then, the program has grown to include more than sixty students and mentors.

(more…)

Baby Boomers Should Get Tested for Hepatitis C!

According to the CDC, all “Baby Boomers” should get tested for hepatitis C. This is based only on age and for this recommendation Baby Boomers are defined as those born between 1945 and 1965

Hepatitis C (HCV) is a viral infection of the liver that can lead to cirrhosis, liver cancer, liver transplant, and death. It has been found to be very common in this age group, and, as they age, the consequences of the infection can be more severe and be irreversible before there are any symptoms at all!

The CDC also recommends that people who test positive for HCV be counseled about alcohol intake and referred to a liver disease specialist, who is familiar with the treatments available. This is particularly important now for several reasons.

(more…)

Leadership in Scientific Education

The Graduate School of Biomedical Sciences has been training many of our nation’s finest scientists for more than four decades and inspiring them to translate their discoveries into effective treatments for human diseases.

Today, Mount Sinai is a leader in bringing “big data” to biomedical sciences, both in our laboratories and in our classrooms. By connecting with the Icahn Institute for Genomics and Multiscale Biology, the Graduate School has developed innovative courses that teach students how to use the new frontier of computational genomics in the laboratory setting. Many of our most devastating diseases are due to complex changes in our genes and how they interact with our environment. Our students learn how to embrace this complexity.

(more…)